p38 Mitogen-activated protein kinase signaling regulates streptococcal M1 protein-induced neutrophil activation and

Songen Zhang1, Milladur Rahman, Su Zhang

  • 1Section for Surgery, Malmö University Hospital, Malmö, Sweden.

Insights

p38 MAPK signaling drives lung injury from Streptococcus pyogenes M1 protein by increasing neutrophil infiltration and edema. Inhibiting this pathway may protect against severe streptococcal lung damage.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Streptococcus pyogenes M1 serotype is a significant cause of streptococcal toxic shock syndrome (STSS) and acute lung injury.
  • The precise molecular mechanisms underlying M1 protein-induced pulmonary damage require further elucidation.

Purpose of the Study:

  • To investigate the role of p38 mitogen-activated protein kinase (MAPK) signaling in M1 protein-mediated acute lung injury.
  • To determine if p38 MAPK inhibition can mitigate M1 protein-induced pulmonary pathology.

Main Methods:

  • Mice were treated with p38 MAPK inhibitors (SB 239063, SKF 86002) before M1 protein challenge.
  • Lung injury parameters (edema, neutrophil infiltration, CXC chemokines) and neutrophil Mac-1 expression were assessed.
  • p38 MAPK phosphorylation and activity were measured via immunoprecipitation and Western blot.
  • Intravital microscopy (IVM) evaluated leukocyte-endothelium interactions in pulmonary microcirculation.

Main Results:

  • M1 protein challenge activated p38 MAPK in the lung, an effect blocked by inhibitors.
  • p38 MAPK inhibition significantly reduced neutrophil infiltration, edema, and CXC chemokine levels.
  • Inhibition decreased Mac-1 expression on neutrophils and reduced leukocyte rolling and adhesion in pulmonary microvasculature.

Conclusions:

  • p38 MAPK signaling is a key regulator of neutrophil recruitment and infiltration in M1 protein-induced acute lung injury.
  • p38 MAPK activity influences CXC chemokine production and neutrophil-endothelial interactions within the lung.
  • Targeting the p38 MAPK pathway presents a potential therapeutic strategy for lung injury associated with streptococcal infections.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inflammation01:38

Inflammation

Overview
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...